What happens if you take too much Ozempic or Wegovy?

Translate to Spanish or other 102 languages!

Poison control centers across the United States are witnessing a concerning increase in inquiries related to semaglutide, an injectable medication used for diabetes management and weight loss. Image for illustration purposes
Poison control centers across the United States are witnessing a concerning increase in inquiries related to semaglutide, an injectable medication used for diabetes management and weight loss. Image for illustration purposes
- Advertisement -
  • Poison control centers across the United States are witnessing a concerning increase in inquiries related to semaglutide, an injectable medication used for diabetes management and weight loss.
  • Reports of inadvertent overdoses have led to hospitalizations in some cases, with symptoms including intense nausea, vomiting and abdominal discomfort.
  • Data from America’s Poison Centers reveals a startling 15-fold increase in semaglutide-related calls between January and November, primarily attributed to dosage errors, amid concerns over the safety of compounded formulations of the drug.

Semaglutide, a glucagon-like peptide-1 receptor agonist or GLP-1 analog, gained approval from the Food and Drug Administration (FDA) in 2017.

The medicine is marketed as Ozempic for diabetes management and Wegovy for weight loss.

Folllow the link below to Medical News Today to read the full story:

- Advertisement -

https://www.medicalnewstoday.com/articles/what-happens-if-you-take-too-much-ozempic-or-wegovy

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Op Ed: Turn awareness into action: Why breast cancer screening matters

Mega Doctor News By Lorena Saenz Gonzalez Breast cancer affects the lives of millions of women and...

STHS and Prominence Health Team Up on Medication Safety

 The Senior Living Seminar offered practical tips on managing prescriptions, avoiding harmful drug interactions and improving overall health outcomes.

Texas Oncology to Host Breast Cancer Awareness Symposium in McAllen on Oct. 16th

The Breast Cancer Awareness Symposium 2026 is an educational and networking event hosted by Texas Oncology and sponsored by Caris Life Sciences, bringing together oncology specialists, surgeons, advanced practice providers, and community healthcare professionals to discuss the latest advances in breast cancer prevention, diagnosis, treatment, survivorship, and reconstruction. The symposium's theme, "Breast Cancer 2026: Early Detection, Modern Care, and Survivorship Through Community Partnership," highlights the importance of multidisciplinary collaboration and patient-centered care

FDA Approves First Heart Valve Designed to Grow with Children

The U.S. Food and Drug Administration today approved the Autus Size-Adjustable Valve, a surgically implanted pulmonary heart valve for pediatric patients with congenital pulmonary valve disease.
- Advertisement -